Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 21 horas · Faron Pharmaceuticalsin osakeanti 5.6.2024–18.6.2024. Osakeannin tavoitteena on yhtiön rahoitusaseman vahvistaminen siten, että yhtiöllä olisi riittävä rahoitus sen vuoden 2024 avaintavoitteiden eli merkittävän kaupallisen yhteistyösopimuksen saavuttamiseksi ja alla kuvattujen tuotekehityksen kustannusten kattamiseksi vuoden 2025 ...

  2. Hace 21 horas · Faron will conduct an offer to retail investors in the United Kingdom on the "REX" platform. The REX Offer (as defined below) is part of an Offering (as defined below) raising approximately EUR 30.7 million. Details of the Offering can be found in the Company's announcement dated 4 June 2024 and available on the Company's website at www.faron ...

  3. Hace 14 horas · Faron Pharmaceuticals Ltd. ("Faron" or the "Company") Proposed REX Retail Offer. Company announcement, 5 June 2024 at 10:00 a.m. (EEST) / 8:00 a.m. (BST) / 3:00 a.m. (EDT) Key Highlights. · Faron will conduct an offer to retail investors in the United Kingdom on the "REX" platform. The REX Offer (as defined below) is part of an Offering (as ...

  4. Hace 21 horas · Faron Pharmaceuticalsilla ja Exel Compositesilla on käynnissä osakeannit. Ylöspäin. Helsingin pörssi avautui keskiviikkona nousuun. JOEL MAISALMI Lukuaika noin 2 min Tiistain laskupäivän jälkeen Helsingin pörssi avautui keskiviikkona nousussa. Iltapäivällä 13.35 aikaan yleisindeksi OMX ...

  5. Hace 13 horas · Key Highlights. Faron will conduct an offer to retail investors in the United Kingdom on the "REX" platform. The REX Offer (as defined below) is part of an Offering (as defined below) raising approximately EUR 30.7 million. Details of the Offering can be found in the Company's announcement dated 4 June 2024 and available on the Company's ...

  6. Hace 21 horas · Faron needs funding to complete phase 2 studies of the blood cancer drug Bexmarilifab. The issue is not an issue of subscription rights. However, in the event of an oversubscription of the public offering, the board prefers the company’s old shareholders who are in the ownership list on Thursday 6/6/24 when accepting subscriptions.

  7. Hace 21 horas · Faron Pharmaceuticals Kesko Atria Aspo Koskisen Spinnova BBS-Bioactive Bone Substitutes. Aamun aiheet. Faron: Kurssilasku on parantanut tuotto-odotusta. Osta

  1. Otras búsquedas realizadas